Randomized Clinical Trial of an Exposure-based Cognitive Therapy for Depression
Phase 2
- Conditions
- Unipolar Depression
- Interventions
- Behavioral: Cognitive-Behavioral Therapy for DepressionBehavioral: Exposure-Based Cognitive Therapy for Depression
- Registration Number
- NCT01012856
- Lead Sponsor
- University of Zurich
- Brief Summary
The purpose of this study is to investigate, if exposure-based cognitive therapy (EBCT) is at least as effective as the established cognitive-behavioral therapy and more effective in its long-term efficacy. Moreover the mechanisms of change of the EBCT are investigated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 142
Inclusion Criteria
- Major Depressive Disorder according to DSM-IV as main diagnosis
- minimum standardized depression scores (BDI >= 17; HAMD >=13)
- minimum age of 18 years
- informed consent to participate voluntarily in the study
- sufficient German language skills
Exclusion Criteria
- acute suicidality
- depressive disorder with mood-incongruent psychotic features
- chronic depressive disorder
- organic cause of depression
- drug-induced depression
- bipolar disorder
- diagnosis of schizophrenia, schizophreniform, schizoaffective disorders, and/or psychosis NOS
- comorbid dysthymia, psychotic disorder (acute or anamnestic), dementia, substance dependence, schizotypal/ borderline/ or antisocial personality disorder
- psychopharmacological treatment other than antidepressants
- antidepressant medication, if it is changed within one month prior to the beginning of psychotherapy
- other simultaneous psychological treatments
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Cognitive-Behavioral Therapy for Depression (CBT) Cognitive-Behavioral Therapy for Depression - Exposure-Based Cognitive Therapy for Depression (EBCT) Exposure-Based Cognitive Therapy for Depression -
- Primary Outcome Measures
Name Time Method severity of depressive symptoms measured by the Beck-Depression-Inventory (BDI-II) end of therapy, 6 month after end of therapy (follow up)
- Secondary Outcome Measures
Name Time Method symptom impairment measured by the Brief Symptom Inventory (BSI) end of therapy, 6-month follow up quality of life measured by the WHO Quality of Life-BREF (WHOQOL-BREF) end of therapy, 6-month follow-up interpersonal problems measured by the Inventory of Interpersonal Problems (IIP) end of therapy, 6-month follow-up avoidance measured by the Cognitive-Behavioral Avoidance Scales (CBAS) end of therapy, 6-month follow-up resources measured by the Bernese Inventory of Resources (RES-K) end of therapy, 6-month follow-up explicit self-esteem measured by the Rosenberg self-esteem scale (RSES) end of therapy, 6-month follow up implicit self-esteem measured by the Self-Esteem Implicit Association Test (SE-IAT) end of therapy goal attainment measured by Goal Attainment Scaling (GAS) end of therapy avoidance motivation measured by the Inventory of Approach and Avoidance Motivation (IAAM) end of therpy, 6-month follow-up motivational incongruence measured by The Incongruence Questionnaire (INC) end of therapy, 6-month follow-up
Trial Locations
- Locations (1)
University of Zurich, Department of Psychology
🇨ðŸ‡Zurich, ZH, Switzerland